Clinical Trials Browser

Phase 2 × Osteosarcoma × Sorafenib × Clear all

NCT01804374 2015-06-17

SERIO

Phase 2 Completed

Sarcoma, Osteosarcoma

NCT00330421 2014-04-30

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Phase 2 Completed

15 enrolled 7 charts

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00889057 2013-03-28

Sorafenib in Relapsed High Grade Osteosarcoma

Phase 2 Completed

Osteosarcoma